Dr. Igor Kagan, MD

Dr. Kagan practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Kagan's NPI, 1245674241, was assigned on April 20, 2013. Dr. Kagan graduated from Keck School of Medicine of USC in 2013. Dr. Kagan holds California license A132630.

Dr. Kagan's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Kagan's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Kagan is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Kagan to 3 more hospitals, 4 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kagan practices, 9 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Kagan's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Kagan is board certified in internal medicine by the American Board of Internal Medicine. Dr. Kagan is licensed in California.

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease, fluid and electrolyte imbalances, hypercalcemia, kidney cysts and parathyroid gland disorder among the conditions Dr. Kagan treats.

CMS data shows 2,990 Medicare services from Dr. Kagan across 16 procedure codes in 2024, for 632 Medicare patients. Medicare paid $229,325 for them.

CMS counts 632 Medicare patients who saw Dr. Kagan in 2024. The largest group is 75 to 84, with 250 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 17% are also on Medicaid. Their average risk score is 2.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kagan's median patient age at 72, with 39% women.

In 2024, Dr. Kagan wrote 1,480 Medicare Part D claims for 257 patients. 84% of them were for generic drugs. CMS names the drug for 1,213 of them, across 28 drugs with 11 or more claims each, at $280,812 in total drug cost. In 2023, CMS named 1,134 claims across 32 drugs.

Dr. Kagan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kagan as offering telehealth.

Dmand AI links 45 papers to Dr. Kagan, published from 2004 to 2025. 2018 was the busiest year, with 5. The most frequent topics are Macaca mulatta, Saccades and Magnetic Resonance Imaging. Dr. Kagan has published most often in Neuroimage. Dr. Kagan's most frequent co-authors are Asha Muthuraman Iyer, MD, PhD and Hiroyuki Oya, MD.

CMS Open Payments shows 59 general payments to Dr. Kagan from 12 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 87% of the total. AstraZeneca Pharmaceuticals LP paid the most, $24,321.

Dr. Kagan graduated from Keck School of Medicine of USC in 2013.

Dr. Kagan is in network with 14 carriers, including Blue Cross Blue Shield of Michigan, Elevance and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.